Seek Returns logo

NMR vs. PJT: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at NMR and PJT, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

NMR trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, PJT is a standard domestic listing.

SymbolNMRPJT
Company NameNomura Holdings, Inc.PJT Partners Inc.
CountryJapanUnited States
GICS SectorFinancialsFinancials
GICS IndustryCapital MarketsCapital Markets
Market Capitalization21.49 billion USD7.07 billion USD
ExchangeNYSENYSE
Listing DateDecember 17, 2001September 22, 2015
Security TypeADRCommon Stock

Historical Performance

This chart compares the performance of NMR and PJT by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

NMR vs. PJT: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolNMRPJT
5-Day Price Return-2.06%1.06%
13-Week Price Return23.60%20.42%
26-Week Price Return2.20%0.24%
52-Week Price Return23.08%44.28%
Month-to-Date Return6.22%-0.34%
Year-to-Date Return14.62%12.80%
10-Day Avg. Volume10.62M0.19M
3-Month Avg. Volume12.16M0.25M
3-Month Volatility20.02%24.82%
Beta1.490.78

Profitability

Return on Equity (TTM)

NMR

9.87%

Capital Markets Industry

Max
38.97%
Q3
21.61%
Median
13.77%
Q1
8.31%
Min
-4.25%

NMR’s Return on Equity of 9.87% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

PJT

96.84%

Capital Markets Industry

Max
38.97%
Q3
21.61%
Median
13.77%
Q1
8.31%
Min
-4.25%

PJT’s Return on Equity of 96.84% is exceptionally high, placing it well beyond the typical range for the Capital Markets industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

NMR vs. PJT: A comparison of their Return on Equity (TTM) against the Capital Markets industry benchmark.

Net Profit Margin (TTM)

NMR

7.19%

Capital Markets Industry

Max
66.67%
Q3
35.11%
Median
23.49%
Q1
13.63%
Min
-15.18%

Falling into the lower quartile for the Capital Markets industry, NMR’s Net Profit Margin of 7.19% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

PJT

10.45%

Capital Markets Industry

Max
66.67%
Q3
35.11%
Median
23.49%
Q1
13.63%
Min
-15.18%

Falling into the lower quartile for the Capital Markets industry, PJT’s Net Profit Margin of 10.45% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

NMR vs. PJT: A comparison of their Net Profit Margin (TTM) against the Capital Markets industry benchmark.

Operating Profit Margin (TTM)

NMR

9.96%

Capital Markets Industry

Max
86.40%
Q3
46.46%
Median
32.80%
Q1
18.32%
Min
-21.87%

NMR’s Operating Profit Margin of 9.96% is in the lower quartile for the Capital Markets industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

PJT

20.14%

Capital Markets Industry

Max
86.40%
Q3
46.46%
Median
32.80%
Q1
18.32%
Min
-21.87%

PJT’s Operating Profit Margin of 20.14% is around the midpoint for the Capital Markets industry, indicating that its efficiency in managing core business operations is typical for the sector.

NMR vs. PJT: A comparison of their Operating Profit Margin (TTM) against the Capital Markets industry benchmark.

Profitability at a Glance

SymbolNMRPJT
Return on Equity (TTM)9.87%96.84%
Return on Assets (TTM)0.58%10.51%
Net Profit Margin (TTM)7.19%10.45%
Operating Profit Margin (TTM)9.96%20.14%
Gross Profit Margin (TTM)39.95%--

Financial Strength

Current Ratio (MRQ)

NMR

0.23

Capital Markets Industry

Max
3.76
Q3
1.89
Median
1.01
Q1
0.54
Min
-0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

PJT

0.93

Capital Markets Industry

Max
3.76
Q3
1.89
Median
1.01
Q1
0.54
Min
-0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

NMR vs. PJT: A comparison of their Current Ratio (MRQ) against the Capital Markets industry benchmark.

Debt-to-Equity Ratio (MRQ)

NMR

10.44

Capital Markets Industry

Max
6.62
Q3
2.84
Median
1.02
Q1
0.32
Min
0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

PJT

0.00

Capital Markets Industry

Max
6.62
Q3
2.84
Median
1.02
Q1
0.32
Min
0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

NMR vs. PJT: A comparison of their Debt-to-Equity Ratio (MRQ) against the Capital Markets industry benchmark.

Interest Coverage Ratio (TTM)

NMR

--

Capital Markets Industry

Max
126.03
Q3
60.98
Median
11.77
Q1
4.95
Min
-36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

PJT

--

Capital Markets Industry

Max
126.03
Q3
60.98
Median
11.77
Q1
4.95
Min
-36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

NMR vs. PJT: A comparison of their Interest Coverage Ratio (TTM) against the Capital Markets industry benchmark.

Financial Strength at a Glance

SymbolNMRPJT
Current Ratio (MRQ)0.230.93
Quick Ratio (MRQ)0.230.93
Debt-to-Equity Ratio (MRQ)10.440.00
Interest Coverage Ratio (TTM)----

Growth

Revenue Growth

NMR vs. PJT: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

NMR vs. PJT: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

NMR

3.55%

Capital Markets Industry

Max
10.26%
Q3
4.86%
Median
2.78%
Q1
1.22%
Min
0.00%

NMR’s Dividend Yield of 3.55% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

PJT

0.40%

Capital Markets Industry

Max
10.26%
Q3
4.86%
Median
2.78%
Q1
1.22%
Min
0.00%

PJT’s Dividend Yield of 0.40% is in the lower quartile for the Capital Markets industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

NMR vs. PJT: A comparison of their Dividend Yield (TTM) against the Capital Markets industry benchmark.

Dividend Payout Ratio (TTM)

NMR

66.06%

Capital Markets Industry

Max
200.72%
Q3
101.92%
Median
57.97%
Q1
32.36%
Min
0.00%

NMR’s Dividend Payout Ratio of 66.06% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

PJT

15.13%

Capital Markets Industry

Max
200.72%
Q3
101.92%
Median
57.97%
Q1
32.36%
Min
0.00%

PJT’s Dividend Payout Ratio of 15.13% is in the lower quartile for the Capital Markets industry. This suggests a conservative dividend policy, with a strategic focus on reinvesting profits for future growth.

NMR vs. PJT: A comparison of their Dividend Payout Ratio (TTM) against the Capital Markets industry benchmark.

Dividend at a Glance

SymbolNMRPJT
Dividend Yield (TTM)3.55%0.40%
Dividend Payout Ratio (TTM)66.06%15.13%

Valuation

Price-to-Earnings Ratio (TTM)

NMR

9.31

Capital Markets Industry

Max
58.89
Q3
31.00
Median
18.54
Q1
12.09
Min
5.24

In the lower quartile for the Capital Markets industry, NMR’s P/E Ratio of 9.31 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

PJT

38.29

Capital Markets Industry

Max
58.89
Q3
31.00
Median
18.54
Q1
12.09
Min
5.24

A P/E Ratio of 38.29 places PJT in the upper quartile for the Capital Markets industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

NMR vs. PJT: A comparison of their Price-to-Earnings Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Sales Ratio (TTM)

NMR

0.67

Capital Markets Industry

Max
14.49
Q3
7.41
Median
4.68
Q1
2.25
Min
0.04

In the lower quartile for the Capital Markets industry, NMR’s P/S Ratio of 0.67 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

PJT

4.00

Capital Markets Industry

Max
14.49
Q3
7.41
Median
4.68
Q1
2.25
Min
0.04

PJT’s P/S Ratio of 4.00 aligns with the market consensus for the Capital Markets industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

NMR vs. PJT: A comparison of their Price-to-Sales Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Book Ratio (MRQ)

NMR

0.83

Capital Markets Industry

Max
9.48
Q3
4.94
Median
2.42
Q1
1.21
Min
0.38

NMR’s P/B Ratio of 0.83 is in the lower quartile for the Capital Markets industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

PJT

24.08

Capital Markets Industry

Max
9.48
Q3
4.94
Median
2.42
Q1
1.21
Min
0.38

At 24.08, PJT’s P/B Ratio is at an extreme premium to the Capital Markets industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

NMR vs. PJT: A comparison of their Price-to-Book Ratio (MRQ) against the Capital Markets industry benchmark.

Valuation at a Glance

SymbolNMRPJT
Price-to-Earnings Ratio (TTM)9.3138.29
Price-to-Sales Ratio (TTM)0.674.00
Price-to-Book Ratio (MRQ)0.8324.08
Price-to-Free Cash Flow Ratio (TTM)3.3211.11